Cerecin

is a Singapore-based biotechnology company that researches and develops novel therapeutics for the treatment of Alzheimer’s disease and CNS disorders...
Read more
Cerecin President & CEO: Charles Stacey

President & CEO

Charles Stacey

CEO Approval Rating

84/100

Est. Annual Revenue
$25-100M
Agree?
Est. Employees
100-250
Agree?
Funding
$259.3M

Cerecin Competitors

1TauRx
2Alzheon
3Alzamend
4Austrianova
5Hummingbird Bioscience
6Bionomics
7Promentis
8Alexza
9PRA International
10Purdue Pharma

Trending Companies